 Raw Story | Why the rejection of Novartis plea is a huge victory for India Firstpost After the granting of compulsory license by the government of India in March last to an Indian company (Natco Pharma) to locally produce Nexavar, a liver-kidney cancer drug, this has been the most eagerly awaited decision in the health sector. Nexavar ... India court ruling could deprive developing nations of patented drugs |
